Marinus Pharma (MRNS) Reports Q4 Loss of $0.45
Marinus Pharma (NASDAQ: MRNS) reported Q4 EPS of ($0.45), versus ($0.26) reported last year.
For earnings history and earnings-related data on Marinus Pharma (MRNS) click here.
Marinus Pharma (NASDAQ: MRNS) reported Q4 EPS of ($0.45), versus ($0.26) reported last year.
For earnings history and earnings-related data on Marinus Pharma (MRNS) click here.